Zobrazeno 1 - 10
of 161
pro vyhledávání: '"D, Van den Weyngaert"'
Autor:
Jwm Martens, Oliver Bogler, Stéphanie Peeters, C. P. Schroder, EP Winer, Isabel T. Rubio, Barbro Linderholm, Larissa A. Korde, Judith Fraser, C.H.M. van Deurzen, Aleksandra Peric, Ingrid Hedenfalk, C. Poncet, Lavinia P. Middleton, Fatima Cardoso, Carrie Cunningham, Catherine M. Kelly, Joanna Vermeij, Peggy L. Porter, Melissa Murray, Sharon H. Giordano, L. Dal Lago, Cecilia Nilsson, M Nowaczyk, CQ Yao, Monika Sobol, Stefan Aebi, E van Leeuwen-Stok, D van den Weyngaert, T Piper, Jms Bartlett, Kathryn J. Ruddy, Kim Benstead, FH Hilbers, Jane Bayani, C. J. van Asperen, N Anouk, Paul C. Boutros, Cheryl Crozier
Publikováno v:
Cancer Research. 79:P6-19
Introduction: Male breast cancer (MBC) is a rare disease accounting for less than 1% of all breast cancers (BC) and 1% of all cancers in males. The clinical management is largely extrapolated from female BC. Several multigene assays are increasingly
Autor:
Jwm Martens, L Middleton, Konstantinos Tryfonidis, E Winer, Kim Benstead, Joanna Vermeij, Peggy L. Porter, Cecilia Nilsson, M Nowaczyk, Sharon H. Giordano, T Goulioti, Judith Fraser, L Slaets, Anieta M. Sieuwerts, Melissa Murray, V de Weerd, Chm van Deurzen, T Piper, L. Dal Lago, E van Leeuwen-Stok, IT Rubio, Barbro Linderholm, Jms Bartlett, C Ponchet, O Bogler, D van den Weyngaert, C Kelly, W Kloosterman, Clifford A. Hudis, Fatima Cardoso, J Bayani, C. P. Schroder, S Aebi, Marcel Smid, Ingrid Hedenfalk, Stéphanie Peeters, C. J. van Asperen, K Ruddy, C Stangle, L Korde
Publikováno v:
Cancer Research. 78:PD7-12
Introduction. Male breast cancer (male BC) is a rare disease for which disease management is extrapolated from females. IMBC, an international consortium, which previously reported on clinico-pathological aspects, now reports on molecular subgroups r
Autor:
B. Schaeken, Steven Lelie, D. Van den Weyngaert, Herwig Janssens, Paul Meijnders, Dirk Verellen
Publikováno v:
Medical Physics. 37:6292-6299
Purpose: To avoid complications in total body irradiation (TBI), it is important to achieve a homogeneous dose distribution throughout the body and to deliver a correct dose to the lung which is an organ at risk. The purpose of this work was to valid
Autor:
Johannes H.A.M. Kaanders, C. Le Bouder, C.M.L. van Herpen, E. Joosens, C. Van Laer, Jan B. Vermorken, H. Nguyen, Dirk Schrijvers, J. A. Castelijns, Ahmad Awada, D. Van den Weyngaert, Joseph Kerger, P.H.M. de Mulder
Publikováno v:
Annals of Oncology, 15, 638-45
Annals of Oncology, 15(4), 638-45. Oxford University Press
Annals of Oncology, 15, 4, pp. 638-45
Annals of oncology
Schrijvers, D, Van Herpen, C, Kerger, J, Joosens, E, Van Laer, C, Awada, A, Van den Weyngaert, D, Nguyen, H, Le Bouder, C, Castelijns, J A, Kaanders, J & Vermorken, J B 2004, ' Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. ', Annals of Oncology, vol. 15, no. 4, pp. 638-45 . https://doi.org/10.1093/annonc/mdh145
Annals of Oncology, 15(4), 638-45. Oxford University Press
Annals of Oncology, 15, 4, pp. 638-45
Annals of oncology
Schrijvers, D, Van Herpen, C, Kerger, J, Joosens, E, Van Laer, C, Awada, A, Van den Weyngaert, D, Nguyen, H, Le Bouder, C, Castelijns, J A, Kaanders, J & Vermorken, J B 2004, ' Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. ', Annals of Oncology, vol. 15, no. 4, pp. 638-45 . https://doi.org/10.1093/annonc/mdh145
Contains fulltext : 57819.pdf (Publisher’s version ) (Closed access) PURPOSE: To determine the safety profile and activity of the combination of docetaxel, cisplatin and 5-fluorouracil (5-FU) in chemotherapy-naive patients with squamous cell carcin
Autor:
D. Van Gestel, Pol Specenier, Kristien Wouters, Marc Peeters, Jan B. Vermorken, Olivier M. Vanderveken, Petr Szturz, Marco Merlano, D. Van den Weyngaert, Marco Benasso, C. Van Laer
Publikováno v:
European Journal of Cancer. 51:S565-S566
Publikováno v:
Radiotherapy and Oncology. 115:S439-S440
Publikováno v:
Bulletin du cancer: radiothérapie
A study was made of 34 patients concerning the palliation effect of radiation therapy in the treatment of superior vena cava syndrome (SVCS). They were seen between 1986-1993, at the Department of Radiotherapy in Middelheim General Hospital, Belgium,
Publikováno v:
Medical physics. 38(11)
The aim of this study was to implement a protocol for reference dosimetry in tomotherapy and to validate the beam output measurements with an independent dosimetry system.Beam output was measured at the reference depth of 10 cm in water for the follo
Publikováno v:
The British journal of radiology
Objective: The purpose of this study was to analyse retrospectively the intensity-modulated radiotherapy (IMRT) results in patients with head and neck cancer (HNC) treated between November 2003 and June 2007. Methods: Patients with early and locoregi
Publikováno v:
Medical physics. 37(12)
To avoid complications in total body irradiation (TBI), it is important to achieve a homogeneous dose distribution throughout the body and to deliver a correct dose to the lung which is an organ at risk. The purpose of this work was to validate the T